Evaluation of the MuSICCA for Measuring Awareness
Evaluating the Validity, Reliability, and Clinical Utility of the Music Therapy Sensory Instrument for Cognition, Consciousness and Awareness (MuSICCA) in Children and Youth With Prolonged Disorders of Consciousness
2 other identifiers
observational
80
2 countries
3
Brief Summary
Prolonged Disorders Of Consciousness (PDOC) include the Vegetative State (VS) and the Minimally Conscious State (MCS) that persist for longer than four weeks. This research seeks to evaluate the validity (accuracy), reliability, and clinical utility (usefulness to clinicians) of the children's version of the Music Therapy Assessment Tool for Awareness in Disorders of Consciousness (MATADOC). The paediatric version is called the Music therapy Sensory Instrument for Cognition, Consciousness and Awareness (MuSICCA). The MATADOC is known to be accurate in diagnosis and has been shown to be clinically useful when working with adults. However, currently, there are no equivalent measures that have been rigorously tested for working with children. Therefore, there is a significant need for a valid and reliable measure, especially when the consequences of misdiagnosis include insufficient care provision, unsuitable treatment programmes, poor identification of intentions to communicate, and insufficient evidence for making difficult decisions around withdrawal of hydration and nutrition. The study will invite participants aged 2-18 years, who the medical team suspect of having a PDOC, from various medical facilities in the UK, Ireland and other English-speaking countries. Parental/carer consent will be required for inclusion in the study. Data collection will occur over 3 years. Each participant will be involved once for a maximum of 7 assessment sessions (4 for the MuSICCA, 1 for the Coma Recovery Scale - Revised (CRS-R), 1 for the Coma/Near Coma Scale (CNC), and 1 for the Nociception Coma Scale Revised (NCS-R)). The MuSICCA assessment protocol involves presenting musical stimuli in three modalities (visual, auditory, and tactile). The participants will be instructed to respond to stimuli and commands. Sessions will be recorded using audio-visual equipment and physical responses will be noted on documentation. The information gained will inform diagnosis and treatment. The participants' behaviours will also be scored on the CRS-R (the gold standard for diagnosis of DOC in adults), the CNC and the NCS-R.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2022
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2019
CompletedFirst Posted
Study publicly available on registry
August 9, 2019
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 30, 2025
April 1, 2025
4.7 years
August 7, 2019
April 24, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Music therapy Sensory Instrument for Cognition, Consciousness and Awareness
Measure of awareness
2 weeks
Coma Recovery Scale - Revised
Diagnostic tool for disorders of consciousness
1 day
Secondary Outcomes (2)
Coma Near Coma Scale
1 day
Nociception Coma Scale
1 day
Eligibility Criteria
Children and young people aged 2-18 years with a suspected disorder of consciousness. They will be identified by the treating clinical team initially.
You may qualify if:
- Between 2-18 years of age
- Assessed by the interdisciplinary team as having a disorder of consciousness
- Be under active investigation for diagnosis of DOC
You may not qualify if:
- Known hearing impairments
- Known profound visual impairments
- Known musicogenic epilepsy
- Seizure disorders that cause frequent and/or prolonged seizures
- English not first language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Children's Trust, United Kingdomlead
- Temple Universitycollaborator
Study Sites (3)
Children's Healthcare of Atlanta
Atlanta, Georgia, 30342, United States
Bethany Children's Health Centre
Bethany, Oklahoma, 73008, United States
The Children's Trust
Tadworth, Surrey, KT20 5RU, United Kingdom
Related Publications (1)
Pool JW, Siegert RJ, Taylor S, Dunford C, Magee W. Evaluating the validity, reliability and clinical utility of the Music therapy Sensory Instrument for Cognition, Consciousness and Awareness (MuSICCA): protocol of a validation study. BMJ Open. 2020 Aug 13;10(8):e039713. doi: 10.1136/bmjopen-2020-039713.
PMID: 32792456DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jonathan W Pool, PhD
Anglia Ruskin University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 7, 2019
First Posted
August 9, 2019
Study Start
April 1, 2022
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
April 30, 2025
Record last verified: 2025-04